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Introduction
Pressure-support ventilation (PSV) is a widely used mode 
of assisted mechanical ventilation (MV), notably during 
the weaning phase [1,2]. Although PSV has been proven 
valuable in several acute clinical conditions [3,4], pre-
deﬁ ned ventilator settings – for example, airway pressure 
(Paw) – that remain unchanged from breath to breath are 
unlikely to provide optimal assistance all of the time.
To improve the match between the patient’s needs and 
the assistance delivered by the ventilator, manufacturers 
have developed several new modes of MV [5,6]. Among 
these new modes we identiﬁ ed proportional-assist 
ventilation (PAV) and neurally adjusted ventilatory assist 
(NAVA).
PAV is a mode of support in which the ventilator 
pressure is proportional to instantaneous ﬂ ow and volume, 
and hence to pressure generated by the respiratory 
muscles [7]. Previous studies have demonstrated that 
PAV improves the synchrony between patient and 
ventilator, during several clinical conditions [8-12]. Based 
on the principles of the equation of motion, software 
(PAV+; Covidien, Boulder, Colorado, USA) has been 
developed that auto matically adjusts the ﬂ ow assist and 
the volume assist so that they always represent constant 
unloading fractions of the measured values of resistance 
and elastance loadings of the respiratory system [13-15]. 
Recent studies demonstrated that PAV+ is a safe and 
eﬃ  cient ventilator mode in critically ill intubated patients 
[16,17]. During PAV the ventilator provides support only 
during the remaining duration of inspiratory eﬀ ort, 
Abstract
Conventional mechanical ventilators rely on pneumatic pressure and fl ow sensors and controllers to detect breaths. 
New modes of mechanical ventilation have been developed to better match the assistance delivered by the 
ventilator to the patient’s needs. Among these modes, neurally adjusted ventilatory assist (NAVA) delivers a pressure 
that is directly proportional to the integral of the electrical activity of the diaphragm recorded continuously through 
an esophageal probe. In clinical settings, NAVA has been chiefl y compared with pressure-support ventilation, one 
of the most popular modes used during the weaning phase, which delivers a constant pressure from breath to 
breath. Comparisons with proportional-assist ventilation, which has numerous similarities, are lacking. Because of 
the constant level of assistance, pressure-support ventilation reduces the natural variability of the breathing pattern 
and can be associated with asynchrony and/or overinfl ation. The ability of NAVA to circumvent these limitations has 
been addressed in clinical studies and is discussed in this report. Although the underlying concept is fascinating, 
several important questions regarding the clinical applications of NAVA remain unanswered. Among these questions, 
determining the optimal NAVA settings according to the patient’s ventilatory needs and/or acceptable level of work 
of breathing is a key issue. In this report, based on an investigator-initiated round table, we review the most recent 
literature on this topic and discuss the theoretical advantages and disadvantages of NAVA compared with other 
modes, as well as the risks and limitations of NAVA.
© 2010 BioMed Central Ltd
Clinical review: Update on neurally adjusted 
ventilatory assist – report of a round-table 
conference
Nicolas Terzi*1,2,3, Lise Piquilloud4, Hadrien Rozé5, Alain Mercat6,7, Frédéric Lofaso8,9, Stéphane Delisle10, Philippe Jolliet4, 
Thierry Sottiaux11, Didier Tassaux4, Jean Roesler12, Alexandre Demoule13, Samir Jaber14, Jordi Mancebo15, Laurent 
Brochard9,16 and Jean-Christophe Marie Richard16,17,18
Report from the Geneva Round Table
R E V I E W
*Correspondence: terzi-n@chu-caen.fr
3CHRU Caen, Service de Réanimation Médicale, Caen F-14000, France
Full list of author information is available at the end of the article
Terzi et al. Critical Care 2012, 16:225 
http://ccforum.com/content/16/3/225
© 2012 BioMed Central Ltd
which can cause limitation when dynamic hyperinﬂ ation 
is present and when the inspiratory trigger is delayed due 
to intrinsic end-expiratory pressure.
Th e other support mode is NAVA, which will be 
discussed in this article. Th ere are several similarities 
between PAV and NAVA, but this ﬁ rst round-table 
meeting focused on NAVA. A vast literature also exists 
concerning PAV, but this topic would require a whole 
chapter and will not be discussed in this current paper; 
hopefully PAV will be the topic of a diﬀ erent round table.
Th e present article is based on an investigator-initiated 
round-table meeting. Th e article aims to review the 
available knowledge on the physiological rationale and 
feasibility of the recently introduced NAVA MV modality. 
Th roughout the article, we place emphasis on the most 
recent ﬁ ndings concerning adjustment of the NAVA 
settings; on the one hand considering speciﬁ c issues 
associated with assisted modes of MV, and on the other 
considering the expecta tions placed upon NAVA.
NAVA is an assist mode of MV that delivers a pressure 
proportional to the integral of the electrical activity of the 
diaphragm (EAdi) [18], and therefore proportional to the 
neural output of the patient’s central respiratory command. 
Th e level of pressure delivered is thus determined by the 
patient’s respiratory-center neural output. With NAVA, 
the ventilator is triggered and cycled-oﬀ  based on the 
EAdi value, which directly reﬂ ects the activity of the 
neural respiratory command. Th e inspiratory airway 
pressure applied by the ventilator is determined by the 
following equation:
Paw = NAVA level × EAdi,
where Paw is the instantaneous airway pressure (cmH2O), 
EAdi is the instantaneous integral of the diaphragmatic 
electrical activity signal (μV), and the NAVA level 
(cmH2O/μV or per arbitrary unit) is a proportionality 
constant set by the clinician.
In February 2011, several European and Canadian 
investigators with clinical results about NAVA available 
in publication or in abstract format organized a round-
table discussion at the Geneva University Hospital to 
describe and discuss recent advances regarding NAVA. A 
representative of the company that commercializes the 
NAVA machine (Maquet Critical Care SA, Sölna, 
Sweden) was invited to attend the meeting in order to 
answer only technical questions. Maquet Critical Care 
SA agreed to sign a disclosure form before the meeting 
specifying that neither the minutes of the meeting nor 
the content of the report could be modiﬁ ed and/or used 
for commercial purposes. Th e main purpose of this 
meeting was for all of the investigators and participants 
to expose their standpoint and questions about NAVA, 
and to share the main results of their studies. Maquet 
Critical Care SA agreed to provide ﬁ nancial support for 
organiz ing the meeting, as detailed at the end of the 
manuscript, but was not responsible for choosing partici-
pants and did not take any part in the writing of this 
report. We here describe the content of the round-table 
discussion, focusing on a selection of the most recent 
studies [19-33] (Table 1).
Main problems with conventional ventilation 
modalities in the ICU
Assisted modes generally aim at synchronizing the 
ventilator insuﬄ  ation to the patient’s eﬀ ort, both to 
optimize comfort and to minimize the work of breathing. 
Th e price to pay for this strategy is a risk of patient–
ventilator asynchrony, which can be deﬁ ned as a mis-
match between the patient’s neural output and the venti-
lator’s inspiratory and expiratory times [34-37]. Th ille 
and colleagues reported that one-quarter of patients had 
high rates of asynchrony during assisted ventilation [34]. 
Frequent asynchrony is associated with a longer duration 
of MV [34,38].
Compelling evidence accumulated over the last decade 
also supports the use of tidal volume (VT) values that are 
lower than those traditionally used. Lower VT values than 
traditionally used have several main advantages: they 
diminish the risk of ventilator-induced lung injury 
[39-41]; they preserve spontaneous breathing by avoiding 
respiratory alkalosis, thus preventing diaphragmatic disuse 
atrophy associated with MV [42-48]; they diminish several 
types of patient–ventilator asynchrony [49]; and they may 
improve the eﬃ  ciency of gas exchange [50]. Assisted 
modes of ventilation that maintain at least part of the 
patient’s spontaneous breathing activity contribute to 
preventing these pulmonary and muscular complications.
Th e new challenge in developing ventilation strategies 
thus consists of minimizing the risk of lung injury, 
avoiding disuse atrophy of the diaphragm, and improving 
the match between the patient’s needs and the assistance 
delivered by the ventilator [6]. New ventilation modes 
have been designed to meet this challenge [5], and NAVA 
is a pressure-assisted mode in which the pressure 
delivered by the ventilator is proportional to the electrical 
activity of the diaphragm recorded continuously through 
an esophageal probe [18]. NAVA theoretically delivers 
pressure proportional to the neural output of the patient’s 
central respiratory command. During NAVA, however, 
reliable positioning of the catheter is mandatory in order 
to obtain a representative EAdi signal from the dia-
phragm. Barwing and colleagues have evaluated whether 
a formula based on the measurement from nose to ear 
lobe to xiphoid process of the sternum (the NEX 
distance) modiﬁ ed for the EAdi catheter (NEXmod) is 
adequate for predicting the accurate position of the 
esophageal probe [51]. Th ey observed in 18 of 25 patients 
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(72%) that at NEXmod the EAdi signal was suitable for 
running NAVA. Th e NAVA mode was possible at the 
optimal position in four patients – the optimal position 
being deﬁ ned by checking three criteria: stable EAdi 
signals, electrical activity highlighted in central leads of 
the catheter positioning tool, and an absence of the p-
wave in the distal lead. Th e authors thus concluded that 
positioning the EAdi catheter using NEXmod gives a 
good approximation in most of the patients.
Moreover, the body position, positive end-expiratory 
pressure (PEEP) and intra-abdominal pressure are factors 
known to inﬂ uence the position of the diaphragm. 
Barwing and colleagues therefore enrolled 20 patients in 
order to evaluate the eﬀ ects of these factors on catheter 
position [52]. Th ey evaluated six diﬀ erent situations 
regarding the PEEP, body position and intra-abdominal 
pressure. Th eir results demonstrated that these factors 
may modify the EAdi catheter optimal position, although 
not compromising a stable signal due to the wide 
electrode array. One can therefore conclude that the 
optimal catheter position should be adjusted after major 
changes in ventilator settings, clinical condition or 
patient positioning.
Management of patient–ventilator synchrony
Th e time lag between the neural inspiratory input and 
the occurrence of a ventilator breath aﬀ ects all steps of 
the respiratory cycle (initiation, insuﬄ  ation, and cycling-
oﬀ  for expiration) [53]. Among the diﬀ erent forms of 
asynchrony, ineﬀ ective triggering (also known as wasted 
eﬀ ort) is the most common during invasive MV. During 
noninvasive ventilation (NIV), leaks at the patient–
ventilator interface impair the function of the pneumatic 
trigger and cycling system [54], thus promoting speciﬁ c 
asynchronies (autotriggering and prolonged insuﬄ  ation) 
[55].
Ineﬀ ective eﬀ orts are explained both by patients’ 
characteristics and by ventilator settings. Th e presence of 
intrinsic PEEP increases the patient eﬀ ort required to 
trigger the ventilator, thereby increasing the likelihood 
that the patient’s inspiratory eﬀ ort will fail to trigger a 
ventilator breath [36,53,56]. A weak inspiratory eﬀ ort, 
which may occur during situations of low respiratory 
drive such as excessive ventilation, is also a risk factor 
and is common in patients receiving high assist levels 
[22] or sedation [38]. An excessive level of pressure 
support is also associated with prolonged insuﬄ  ation, 
thus promoting hyperinﬂ ation and intrinsic PEEP. Reduc-
tion of ineﬀ ective eﬀ orts is often possible through a 
careful optimization of ventilator settings, at least in 
short-term studies. Reducing VT during PSV can improve 
most factors contributing to ineﬀ ective eﬀ orts [49]. Th ille 
and colleagues showed that wasted eﬀ orts could be 
decreased without increasing the patient’s work of Ta
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breath ing, with the main goal of decreasing the pressure-
support level to obtain VT values of about 6 ml/kg 
predicted body weight [49]. Because high pressure-
support levels are associated with prolonged insuﬄ  ation 
beyond the end of the patient’s neural inspiratory time, 
another useful means of decreasing wasted eﬀ orts 
consists of adjusting the inspiratory time by increasing 
the ﬂ ow threshold of the cycling criterion [49,57].
Neurally adjusted ventilatory assist and asynchrony
NAVA involves the transesophageal recording of dia-
phrag matic electrical activity using speciﬁ cally designed 
technology to minimize measurement errors. Th e EAdi 
signal reliably monitors and controls the ventilatory assist 
[58]. During NAVA, the EAdi triggers the assist when the 
patient initiates an inspiratory eﬀ ort – even during 
expiration with intrinsic PEEP – and a decrease in EAdi 
terminates the assist. NAVA does not therefore depend 
on measurements of airway pressure or ﬂ ow and keeps 
the assist synchronous with the inspiratory eﬀ orts (inde-
pendent of the presence of leaks or intrinsic PEEP) 
[19,21,22,25,29,59]. NAVA thus has two important 
features: the delivered pressure is, in theory, synchronous 
with the diaphragmatic activity, and the VT is completely 
controlled by the output of the patient’s respiratory 
control center [18].
A frequent form of minor patient–ventilator asyn-
chrony is a long inspiratory trigger delay (time lag 
between the onset of neural inspiration, then the 
detection of a breath initiated by the patient and, ﬁ nally, 
the onset of ventilator pressurization). Several factors 
may increase the inspiratory trigger delay during PSV, 
including the presence of intrinsic PEEP and suboptimal 
ventilator performance [60]. Th e cycling-oﬀ  delay is the 
time diﬀ erence between the end of the neural inspiratory 
ramp and the end of ventilator pressurization. Piquilloud 
and colleagues compared these delays and their conse-
quences between NAVA and PSV in a group of 22 
patients intubated for acute respiratory failure. Th e 
inspiratory trigger delay, the excess inspiratory time, and 
the frequency of patient–ventilator asynchrony were 
compared between the two modes [26]. Compared with 
PSV, NAVA substantially improved patient–ventilator 
synchrony by reducing the inspiratory trigger delay and 
the total number of asynchrony events, and by improving 
expiratory cycling-oﬀ .
Increasing the level of ventilatory assist with standard 
modes may expose the patient to potentially dangerous 
levels of volume and pressure, and to uncoupling between 
the patient’s neural output and ventilator assistance. In 
contrast to PSV, there is good evidence that NAVA oﬀ ers 
protection against excessive Paw and VT values because 
there is a downregulation of EAdi in response to increas-
ing assistance levels: the net result is a decrease in the 
amount of assistance provided [20,21,61-63]. Th e absence 
of a VT increase with increasing NAVA levels suggests 
that the Hering–Breuer reﬂ ex is operative [64], stopping 
the output from the respiratory control center at the 
same VT level, irrespective of the NAVA level. Unloading 
of the respiratory muscles is always partial, as some level 
of spontaneous activity is maintained, and patient–
ventilator synchrony is improved.
Several studies have evaluated the impact of increasing 
PSV levels versus NAVA levels using similar methods of 
setting the ventilator [20-22,25]. Inspiratory pressure 
support was titrated in order to obtain 6 to 8 ml/kg 
predicted body weight during active inspiration. During 
PSV, the ventilator function ‘NAVA Preview’ estimates 
the NAVA level that would achieve the same peak 
inspiratory pressure. All studies performed in the ICU 
consistently showed that NAVA, in contrast to PSV, 
averted the risk of overassistance when the assist level 
was increased gradually. NAVA also improved patient–
ventilator synchrony, in contrast to PSV, regardless of the 
underlying diagnosis. Very high levels of NAVA, however, 
might result in unstable periodic breathing patterns with 
delivery of high tidal volume followed by periods of 
apnea and signs of discomfort [65]. To separate the 
eﬀ ects of neural triggering and those of proportional 
assis tance, Terzi and colleagues studied a selected popu-
la tion of patients recovering from acute respiratory distress 
syndrome, using NAVA with two inspiratory triggers: the 
EAdi signal and the inspiratory ﬂ ow threshold used 
previously for PSV [25] (Figure  1a,b). Not only propor-
tional assistance but also neural triggering improved 
patient–ventilator synchrony in these patients during the 
weaning process.
All of the available studies of NAVA in ICU patients 
have limitations regarding the clinical applicability of the 
results. Except for two studies [19,25], the patient popu-
lation was heterogeneous in terms of the cause of respira-
tory failure. Th e evaluation time was relatively short in 
eight studies, but not for two studies [24,27].
Matching alveolar ventilation to metabolic 
demand: role for the neural controller – variability
Interestingly, and for reasons that are not yet fully 
understood, NAVA compared with PSV seemed to im-
prove the partial pressure of oxygen in arterial blood in 
some studies independent of changes in the partial 
pressure of carbon dioxide in arterial blood (PaCO2) 
[25,27]. One hypo thesis is that the continuous spon ta-
neous inspira tory activity during NAVA improves the 
matching between ventilation and perfusion. Earlier 
studies had established that partial ventilatory support 
allowing some degree of spontaneous breathing activity 
using modes of ventilation other than NAVA improved 
the ventilation/perfusion relationship compared with 
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fully controlled MV [66]. In addition, NAVA allows a 
more natural breathing pattern characterized by greater 
variability, which may also contribute to improve gas 
exchange [67] (see below).
According to the principle of homeostasis, the closed 
loop that regulates PaCO2 comprises: sensors (or detec-
tors), which are chemoreceptors; a controller (or com-
para tor), which is the central respiratory command; and 
Figure 1. Example of recording during neurally adjusted ventilatory assist and pressure-support ventilation. (a) Neurally adjusted 
ventilatory assist using the neural trigger: no asynchrony was observed. (b) Pressure-support ventilation: wasted eff orts are underscored. Each 
wasted eff ort is identifi ed by a blue rectangle.
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eﬀ ectors, which are the respiratory muscles. Each com-
po nent controls the next component in the loop, and the 
eﬀ ectors change their activity (that is, adapt) to keep the 
PaCO2 value relatively constant. In other words, EAdi 
and therefore the breathing pattern must adapt to a 
variety of conditions to maintain PaCO2 within the 
normal range. Another regulatory mechanism is optimi-
za tion of the work of breathing. For example, the rate 
and/or the depth of breathing can be adjusted to mini-
mize the energy expenditure at a given respiratory eﬀ ort 
and/or to minimize the stretch on the lungs.
Any strategy based on automated feedback control of 
ventilatory support should ideally require neural infor-
mation on the lung volume, rate of lung volume change, 
and transpulmonary pressure, which are provided by 
mechano receptors in the lungs and chest wall. Finally, the 
varia bility and complexity of the breathing pattern are 
inﬂ u enced by several factors, including the load–capacity 
relationship of the respiratory system [68-70], vagal aﬀ er-
ent traﬃ  c to the brain [71], and the activity of the central 
pattern generators [72].
Ventilatory activity is nonlinear in nature and exhibits 
chaos-like mathematical complexity [72,73]. Variability is 
a mathematically complex notion, often expressed using 
the coeﬃ  cient of variation, which is the ratio of the 
standard deviation over the mean. However, the com-
plexity of ﬂ ow and EAdi variability can also be described 
using noise titration, the largest Lyapunov exponent, 
Kolmogorov–Sinai entropy, and three-dimensional phase 
portraits [74,75]. Schmidt and colleagues used these 
methods to compare respiratory variability and com-
plexity during PSV and NAVA [23]. Compared with PSV, 
NAVA increased breathing pattern variability and ﬂ ow 
complexity without changing EAdi complexity. Accord-
ingly, when the NAVA level was increased from zero to a 
high level in healthy individuals, they adapted their 
inspiratory activity to the NAVA level in order to control 
VT and to regulate PaCO2 over a broad range of NAVA 
settings [63]. In contrast, during high-level PSV, VT 
became almost entirely determined by the ventilator and 
hypocapnia developed as previously shown in healthy 
subjects [76,77]. Th ese diﬀ erences between NAVA and 
PSV establish that with NAVA, even at a high level of 
assis tance, VT is not imposed by the ventilator but remains 
under the control of the patient’s central respiratory 
command. NAVA therefore decreases the risk of over-
assistance. Th e extent to which the preserved variability 
associated with NAVA is beneﬁ cial remains to be estab-
lished. Whether variability restoration could be used to 
adapt NAVA settings also warrants further studies, as 
well as the development of speciﬁ c tools for assessing 
variability at the bedside.
Patients with respiratory failure probably adjust their 
breathing activity to achieve the best compromise 
between the muscular eﬀ ort needed to breathe and the 
sensory cost of tolerating elevated PaCO2 levels. NAVA 
acts as an additional external cost-free muscle controlled 
by the central respiratory command. NAVA therefore 
does not seem to alter the closed loop that controls the 
PaCO2 and respiratory pattern optimization. Accordingly, 
when introducing NAVA in patients with respiratory 
failure, progressively increasing the NAVA level allows 
the PaCO2 (that is, VT) to improve to the optimal value. 
Further NAVA level increases then lead to respiratory 
eﬀ ort adjustments aimed at maintaining this optimal 
PaCO2 value, but do not change VT [20].
Moreover, Karagiannidis and colleagues intended 
recently to evaluate the physiological eﬀ ect of extra cor-
poreal membrane oxygenation on the pattern of 
breathing in patients with severe lung failure treated with 
NAVA [78]. Th ey demonstrated that a downregulation of 
extra corporeal exchange gas transfer caused an imme-
diate upregulation of ventilation. Eucapnia under NAVA 
was preserved because the patients adjusted their minute 
ventilation to their needs. Th ese interesting data high-
lighted once again that the ventilatory adaptation to 
maintain normocapnia remains under NAVA.
How can the optimal NAVA level be determined?
Determining the optimal NAVA level remains challeng-
ing, and several methods have been suggested. Contrary 
to PSV and as already described, NAVA generates VT 
levels that can remain constant independent of the assist 
level once the patient’s ventilation needs appear to be 
satisﬁ ed [20]. Consequently, NAVA settings cannot be 
adjusted based solely on VT (and/or the corresponding 
PaCO2 target).
Brander and colleagues tried to ﬁ nd the best NAVA 
level using breathing pattern analysis during a titration 
procedure [20]. Titration consisted of starting at a 
minimal assist level of around 3  cmH2O and then 
increasing the NAVA level every 3  minutes in steps of 
1  cmH2O per arbitrary unit (the amount of microvolts 
recorded from the EAdi signal). Th e response in terms of 
VT and Paw was biphasic. During the ﬁ rst phase, VT and 
Paw increased while the esophageal pressure–time 
product (that is, inspiratory muscle eﬀ ort) and EAdi 
decreased. Further increases in the NAVA level (second 
phase) did not signiﬁ cantly change Paw or VT but 
continued to decrease the esophageal pressure–time 
product and EAdi. Th e ﬁ rst phase may thus indicate an 
insuﬃ  cient NAVA level to supplement the patient’s weak 
breathing eﬀ ort, while the beginning of the second phase 
may correspond to the minimal assist level that satisﬁ es 
the patient’s respiratory demand. Th e optimal (or 
adequate) NAVA level may thus be indicated by the 
inﬂ ection point of the airway pressure trend graph during 
a stepwise increase in the NAVA level (Figure 2). In this 
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study the patients were ventilated with these settings for 
3  hours without experiencing adverse hemodynamic or 
respira tory events [20]. Interestingly, the optimal NAVA 
level occurred at about 75% of the highest EAdi obtained 
with the minimal NAVA level and PEEP [20].
As suggested, titration of the NAVA level may be 
performed by systematically increasing the NAVA level 
to determine the optimal setting with regard to unloading 
patient’s respiratory muscles [20,61,79]. During a recent 
observational study, transferring patients to NAVA was 
uneventful and the NAVA level contributed to adjust-
ments of the preset NAVA level [80]. Interpretation of 
several interacting physiological parameters might be 
diﬃ  cult in cases in which there is no marked decrease in 
EAdi during NAVA titration [80]. An automated 
approach enabled faster identiﬁ cation of the best NAVA 
level with a good accuracy [81].
Instead of stepwise titration, Rozé and colleagues tried 
to ﬁ nd the best NAVA level using an EAdi target of 60% 
of the highest EAdi value recorded during spontaneous 
breathing [24]. Th is measurement was reassessed daily 
using a spontaneous breathing trial with a pressure-
support level of 7 cmH2O and no PEEP. Th is method 
proved feasible and well tolerated until extubation 
(Figure 3). Th e 60% of the highest EAdi value threshold 
was based on a muscular rehabilitation protocol developed 
using data on diaphragmatic electromyogram activation 
during exercise [82]. Whether this approach is also 
optimal during assisted ventilation needs further evalu-
ation. It is worth noting that EAdi measured during the 
daily spontaneous breathing trial increased steadily over 
time in all patients until successful extubation [24]. Th is 
improvement probably originated in multiple factors, 
including discontinuation of sedative agents and gradual 
restoration of the functional electrophysiologic activity of 
the diaphragm. Monitoring diaphragmatic activity may 
be of clinical interest and could be achieved using the 
NAVA electrode.
Using EAdi analysis to titrate NAVA is an interesting 
approach that could potentially be easier to use than the 
breathing pattern analysis method of Brander and 
colleagues (VT change during titration) [20]. Th e EAdi 
target of 60% of the highest EAdi value with 7 cmH2O of 
PSV proposed by Rozé and colleagues should be used 
cautiously [24], as Brander and colleagues found that the 
EAdi at the optimal NAVA level was equal to 75% of the 
highest EAdi value recorded with minimal NAVA 
(inspiratory Paw above PEEP  = 3  cmH2O) [20]. Further 
studies are clearly needed to better determine the optimal 
EAdi target.
Noninvasive ventilation, sleep and NAVA
NIV is a speciﬁ c clinical situation during which the 
occurrence of leaks may greatly aﬀ ect patient–ventilator 
interactions, thereby complicating the determination of 
optimal ventilator settings. In a study by Vignaux and 
colleagues, more than 40% of patients experienced 
various types of asynchrony during conventional NIV 
and the asynchrony rate correlated with the level of 
leakage [83]. With NAVA, assistance is delivered based 
on neural triggering, which is not aﬀ ected by leakage. 
NAVA may thus, in theory, diminish asynchrony events, 
thereby improving the tolerance of NIV. New software 
for NIV has been developed using NAVA technology. 
With this speciﬁ cally designed algorithm, NIV assistance 
is triggered and cycled-oﬀ  by the neural diaphragmatic 
activity, which would be expected to improve patient–
ventilator synchrony during NIV. Th is hypothesis has not 
yet been fully investigated.
A study of NIV–PSV with a helmet interface in healthy 
volunteers compared asynchrony with a neural trigger 
and a conventional pneumatic trigger [59]. Increasing 
PSV levels and respiratory rates applied with neural 
trigger ing and cycling-oﬀ  produced signiﬁ cantly less 
impair ment of synchrony, trigger eﬀ ort, and breathing 
Figure 2. Titration of the neurally adjusted ventilatory assist 
level according to Brander and colleagues’ procedure. The 
neurally adjusted ventilatory assist (NAVA) level is increased step by 
step. VT, tidal volume; Paw, airway pressure; cmH2O/AU, cmH2O per 
arbitrary unit (the amount of microvolts recorded from the electrical 
activity of the diaphragm signal).
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comfort, compared with conventional pneumatic trigger-
ing and cycling-oﬀ .
Cammarotta and colleagues recently compared NAVA 
and NIV–PSV delivered through a helmet interface in 
postextubation hypoxemic patients [32]. Ten patients 
underwent three 20-minute trials of helmet NIV in PSV, 
NAVA, and PSV again. Th e authors demonstrated that 
there was less asynchrony during NAVA than during PSV 
and no diﬀ erence in gas exchange, although there were 
more leaks during NAVA. Moreover it is important to 
underline that the PSV mode chosen was speciﬁ cally 
dedicated to NIV, whereas the NAVA mode dedicated to 
NIV that is now currently available did not exist at the 
time of this study.
Recent data obtained in low-birth-weight infants 
indicate that NAVA can maintain synchrony – both in 
terms of timing and proportionality – even after extu-
bation in patients with an excessively leaky interface 
under NIV (all infants in this study were ventilated using 
a single nasal prong) [29].
Another consideration for NIV that deserves attention 
in the near future is the impact on swallowing, phonation, 
and sleep quality, most notably when NIV is used for 
several days. Improvements in swallowing performance 
have been reported in neuromuscular patients receiving 
MV compared with spontaneous breathing [84,85]. Th e 
close relationship between the muscles involved in 
swallowing and those contributing to inspiration was 
evidenced by Orlikowski and colleagues using an original 
method of tongue-strength measurement. Th e signiﬁ cant 
tongue weakness observed in 16 weak patients with 
Guillain–Barré syndrome correlated with the alterations 
in respiratory parameters [86]. Additional physiological 
studies are required to document the potential beneﬁ ts of 
NAVA on swallowing–breathing interactions during NIV.
Sleep quality during NIV has been shown to be a 
predictor of success or failure [87]. Sleep quality can also 
be improved compared with standard NIV settings by 
careful physiological titration of the ventilator settings 
[88]. Patient–ventilator asynchrony can cause sleep dis-
rup tion. Bosma and colleagues demonstrated that PAV, a 
mode of partial ventilatory support in which the venti-
lator applies pressure in proportion to the inspiratory 
load, was more eﬀ ective than PSV in matching the 
ventilatory requirements to the level of ventilator assis-
tance, thereby resulting in fewer patient–ventilator 
asynchronies and better quality of sleep [11]. Delisle and 
colleagues recently obtained sleep recordings during a 
Figure 3. Change in neurally adjusted ventilatory assist according to maximum diaphragmatic electrical activity during spontaneous 
breathing. Electrical activity of the diaphragm (EAdi) values during 1 hour, each point representing the mean value over 1 minute. EAdi variations 
occurred before, during, and after a spontaneous breathing trial (SBT). Maximum EAdi was 21 μV after a SBT of 3 minutes and allowed a reduction 
in the neurally adjusted ventilatory assist (NAVA) level from 2.4 to 2.2 cmH2O/μV in order to obtain EAdi values after the SBT of about 13 μV (60% of 
maximum EAdi). Arterial blood gases were not changed by the NAVA level modifi cation.
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crossover study comparing NAVA and PSV in 14 mecha-
nically ventilated patients [89]. Each condition was 
studied for 4 hours, and recordings were obtained over 
19 consecutive hours in all. Patient–ventilator asyn-
chrony varied signiﬁ cantly across sleep stages, and no 
asynchrony occurred with NAVA. Overassistance occur-
red only with PSV, which probably explained the 
improvements in physiological indices of sleep quality 
observed with NAVA.
Neurally adjusted ventilatory assist in children and 
infants
MV in children and in low-birth-weight infants is more 
diﬃ  cult to apply than in adults and has several speci-
icities. First infants take a very small tidal volume, have a 
rapid respiratory rate, have a limited chest wall muscu-
lature, and have variable and ﬂ uctuating lung compliance. 
Second, most neonatal units use uncuﬀ ed tracheal tubes 
for fears of pressure necrosis and air leak is always 
present, making reliable measurements and triggering 
problematic. Th ird, ventilators that are eﬃ  cient in adults 
are not systematically eﬃ  cient in children and infants, 
mainly because the inspiratory triggers are not suﬃ  ci-
ently sensitive for early detection of infants’/children’s 
inspiratory eﬀ ort [90].
Whether or not the respiratory drive of the preterm 
infant is suitable to control MV is unknown. Beck and 
colleagues ﬁ rst evaluated patient–ventilator interaction 
with NAVA in seven very-low-birth-weight infants [29]. 
As suggested by previous animal studies [91], they 
demonstrated that NAVA could be implemented for a 
short-term period, both invasively and noninvasively, in 
infants with body weight as low as 640 g up to 3 years old. 
During invasive ventilation with NAVA, EAdi and venti-
lator pressure were correlated and patient–ventilator 
synchrony was improved compared with the other mode. 
Moreover, this synchrony persisted after extubation while 
ventilating the patient with an excessively leaky interface. 
After this ﬁ rst physiological demonstration, Bengtsson 
and Edberg demonstrated the clinical feasibility and 
safety with use of NAVA in pediatric patients [30]. 
Similarly, Breatnach and colleagues compared NAVA 
(with a neural trigger) and PSV (with a pneumatic trigger) 
in 16 ventilated infants [31]. Th is prospective crossover 
comparison demonstrated that ventilation with NAVA 
improved patient–ventilator synchrony.
Furthermore, Alander and colleagues recently compared 
NAVA with pressure-controlled ventilation for newborns 
and with pressure-regulated controlled ventilation for 
children older than 3 months (with conventional trigger 
modes: pressure and ﬂ ow trigger) [92]. In this prospective 
cross-over study, 18 patients requiring MV were random-
ized for 10 minutes with the diﬀ erent modes. During 
NAVA, the peak airway pressure was lower, the 
respira tory rate was 10 breaths/minute higher than in the 
pressure group, and patient–ventilator synchronization 
was improved. However, there were no diﬀ erences in 
tidal volume and in oxygen saturation.
To evaluate the eﬀ ects of the neural trigger on trigger 
delay, ventilator response time, or work of breathing, 
Clement and colleagues conducted a study in 23 pediatric 
patients aged 0 to 24  months with a diagnosis of bron-
chio litis presenting respiratory failure requiring MV [33]. 
Th e authors compared the neural trigger and the 
pneumatic trigger using similar NAVA assistance, and 
observed that the trigger delay, the ventilator response 
time, and the work of breathing were reduced by the 
neural trigger.
Finally, all of these studies seem to demonstrate the 
feasibility of and a potential advantage for NAVA in 
children compared with the other assisted ventilatory 
modes. Because patient–ventilator synchrony is improved 
with NAVA, the children may require lower doses of 
sedation with this mode of MV [93], which could reduce 
the time of MV.
Future research
Clinical studies obtained in critically ill patients conﬁ rm 
many of the expected short-term physiological beneﬁ ts 
associated with NAVA, as discussed above.
Particularly, NAVA seems to markedly improve the 
problems of nonsynchronization between the patient and 
the ventilator and the problems of risk of overventilation – 
including the risk of ineﬀ ective or missed inspiratory 
eﬀ orts due to intrinsic PEEP observed in chronic 
obstructive pulmonary disease patients, or to a rapid 
breathing frequency with a very small tidal volume 
observed in pediatric patients.
In addition, NAVA minimizes the risk of overinﬂ ation 
because the duration and level of pressurization remain 
under respiratory-center control, and minimizes the risk 
of diaphragmatic inactivity because the presence of 
pressure assistance requires the presence of this inspira-
tory activity.
A preserved respiratory muscle function is pivotal for 
weaning from MV [44]. By using NAVA, which out-
performs the previous modes of MV for adequately 
assisting the patient’s inspiratory eﬀ ort without inducing 
patient/ventilator dyssynchrony, a reduction in the dura-
tion of MV could be expected. Studies are needed to 
evaluate the best time to begin the weaning process with 
NAVA.
Th e NAVA setting is an important question not yet 
fully resolved. If clinicians are accustomed to set a PSV 
level, this is not the case for NAVA. Furthermore, because 
the breathing pattern is less modiﬁ ed by the NAVA 
setting than during PSV, it is much less informative for 
NAVA adjustment. As described above, the literature 
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suggests that the adjustment should consider the electro-
myographic activity of the diaphragm, but this method is 
not simple. As recently proposed, a direct evalu ation of 
patient comfort and sense of dyspnea for the NAVA 
setting should be evaluated [23].
Finally, the next research step will be to evaluate NAVA 
over longer periods, in order to know whether this mode 
can replace the modes usually used during MV and the 
weaning period, like PSV. Appreciating the safety, the 
feasibility and the constraints of this technology will be 
useful. It is therefore necessary to test, during the total 
weaning period, the eﬀ ectiveness of the esophageal probe 
and to know whether it is regularly necessary to adjust 
the probe position. One of the most diﬃ  cult questions to 
address, however, is in which situations it is not desirable 
to let the respiratory centers drive the ventilation. 
Situations of severe metabolic acidosis, of high 
respiratory drive and of high catecholamine levels may 
induce situations of extreme hyperventilation, which may 
be dangerous for the lungs. When sedation and/or paralysis 
become necessary is therefore an important question to 
address before widespread use of this mode [94].
Conclusion
NAVA, which is based on an original physiological 
concept, adds new knowledge on patient–ventilator 
interactions during spontaneous breathing, thus helping 
to unravel the complex mechanisms involved in breathing 
control during MV. Th ere is compelling evidence that 
NAVA, as well as the PAV+ software, improves patient–
ventilator interactions and increases respiratory varia-
bility in comparison with PSV. Th is advantage holds 
potential for many applications. Th e short-term and 
long-term experi ence with NAVA, however, remains 
scant. Further clinical studies are needed to assess the 
feasibility and safety of NAVA. A key challenge is how to 
determine the best NAVA settings according to the 
patient’s ventilatory needs and the acceptable level of 
work of breathing.
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